Jefferies Downgrades LianBio to Hold, Lowers Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Michael Yee has downgraded LianBio (NASDAQ:LIAN) from Buy to Hold and reduced the price target from $7 to $4.
December 22, 2023 | 10:32 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jefferies downgraded LianBio from Buy to Hold and lowered the price target from $7 to $4, indicating a more cautious view on the stock's future performance.
Analyst downgrades typically lead to a negative short-term reaction in the stock market as they suggest a less optimistic outlook on the company's performance. The reduction in price target further implies that the stock may not have as much upside potential as previously thought.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100